CA
NZ
UK
AU
IND
US
No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. Recursion, an AI-driven drug discovery company, fell 3.99% to USD 3.85 on volume of 30.79 million shares, 1.5 times its …
Scinai Immunotherapeutics, a Jerusalem biopharma that also runs a contract development and manufacturing business, announced on October 13 that Scinai Biopharma Services signed a definitive agreement worth about USD 5.1 million in committed base fees for chemistry, manufacturing and controls development and clinical manufacturing …
No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. Tenon Medical is a medical device company whose Catamaran system treats sacroiliac joint dysfunction, and it fell 2.01% to USD …
Bristol Myers Squibb (NYSE:BMY) fell USD 0.95 to USD 56.63 on 12.927 million shares, about 1.2 times its 3-month average of 11.217 million. The news was positive but mixed: the Phase 3 trial of admilparant in idiopathic pulmonary fibrosis met its primary endpoint at …
No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. China Pharma Holdings is a Haikou-based specialty pharmaceutical company with eight GMP-certified product lines, listed on NYSE American. NYSE American …
Hyperfine, maker of the Swoop portable MRI brain imaging system, issued a preliminary third-quarter 2026 update showing revenue of about USD 6.0 million, up roughly 53% sequentially and about 55% year over year, and net cash burn of about USD 5.6 million, down about …
No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. DataMeds AI, a Tampa-based health IT company that changed its name from Wellgistics Health in July and began trading as …
No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. Onconetix is a Cincinnati-based commercial-stage biotechnology company that owns Proclarix, an in vitro diagnostic blood test used with PSA to …
No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. RedHill Biopharma, a Tel Aviv and Raleigh specialty pharmaceutical company, sold its 70% stake in Talicia to Apotex for USD …
DRI Healthcare Trust moved from an implied USD 12.79 to USD 11.62 on only 519 units, so a single small order could explain the whole decline. No company release, filing or analyst note dated October 13, 2026 was found. Relative volume of 1.38 sounds …
Please wait processing your request...